Gene · 1457
Papers3,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A ligand-receptor interactome of the bone tumor microenvironment in multiple myeloma bone pain. | Pain | 2025 | 40721388 | PubTator, text mining | PubMed |
| OCNDS core features are conserved across variants, with loop-region mutations driving greater symptom burden. | Front Hum Neurosci | 2025 | 40677894 | PubTator, text mining | PubMed |
| CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy. | Cancer Lett | 2025 | 40623542 | PubTator, text mining | PubMed |
| Prenatal Diagnosis of Okur-Chung Syndrome: Ultrasound Findings and Implications of CSNK2A1 and KCNQ5 Variants. | Matern Fetal Med | 2025 | 40620262 | PubTator, text mining | PubMed |
| Kinases Associated with Herpes Zoster Virus Infection Unveiled by Phosphoromics Profiling. | Infect Drug Resist | 2025 | 40469476 | PubTator, text mining | PubMed |
| Multifunctional Tandem Peptide Mediates Targeted siRNA Delivery to Ovarian Cancer Cells. | ACS Appl Bio Mater | 2025 | 40465375 | PubTator, text mining | PubMed |
| Scaffold hopping and sidechain modification from a flavone scaffold lead to discovery of potent, selective CK2A2 inhibitors with favorable properties for CNS activity. | Bioorg Med Chem | 2025 | 40367913 | PubTator, text mining | PubMed |
Membrane-anchored tissue inhibitor of matrix metalloproteinase (TIMP)-1 promotes cell death in head and neck cancer by inducing DNA damage, accumulating collagen II and disrupting cell survival mechanisms. | Int J Biol Macromol | 2025 | 40306502 | PubTator, text mining | PubMed |
| Genetic aetiologies in relation to response to the ketogenic diet in 226 children with epilepsy. | Brain Commun | 2025 | 40290421 | PubTator, text mining | PubMed |
| Time- and dose-dependent effects of CIGB-300 on the proteome of lung squamous cell carcinoma. | Biol Chem | 2025 | 40261874 | PubTator, text mining | PubMed |
| A CK2α' mutant indicating why CK2α and CK2α', the isoforms of the catalytic subunit of human protein kinase CK2, deviate in affinity to CK2β. | Biol Chem | 2025 | 40223482 | PubTator, text mining | PubMed |
| Identifying diagnostic markers and establishing prognostic model for lung cancer based on lung cancer-derived exosomal genes. | Cancer Biomark | 2025 | 40179422 | PubTator, text mining | PubMed |
| LigExtract: Large-scale Automated Identification of Ligands from Protein Structures in the Protein Data Bank. | Genomics Proteomics Bioinformatics | 2025 | 40036758 | PubTator, text mining | PubMed |
| Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening. | Front Pharmacol | 2025 | 40028162 | PubTator, text mining | PubMed |
| Adrenal Hypoplasia: A Diagnostic and Clinical Challenge. | Cureus | 2025 | 40013223 | PubTator, text mining | PubMed |
| Novel role of the SOX4/CSNK2A1 axis in regulating TOP2A phosphorylation in breast cancer progression. | FASEB J | 2025 | 39931818 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal pre-metastatic subsets and therapeutic targets in penile carcinoma. | iScience | 2025 | 39925432 | PubTator, text mining | PubMed |
| A Dual Diagnosis of Okur-Chung Neurodevelopmental Syndrome and Becker Muscular Dystrophy: Inquiry Into the Lower Limits of Neurodevelopmental Functioning Attributable to Muscular Dystrophy. | Brain Behav | 2025 | 39915227 | PubTator, text mining | PubMed |
| PhosNetVis: A web-based tool for fast kinase-substrate enrichment analysis and interactive 2D/3D network visualizations of phosphoproteomics data. | Patterns (N Y) | 2025 | 39896259 | PubTator, text mining | PubMed |
| Metastatic melanoma: An integrated analysis to identify critical regulators associated with prognosis, pathogenesis and targeted therapies. | PLoS One | 2025 | 39820173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1457/papers?page=3